Savara Starts Phase 3 Trial of AeroVanc for MRSA Lung Infections in Cystic Fibrosis Cystic Fibrosis News Today By John Harbison|2017-10-02T12:31:50-08:00October 2, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Savara Starts Phase 3 Trial of AeroVanc for MRSA Lung Infections in Cystic Fibrosis Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
